These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14594327)

  • 1. The Quick and Owren prothrombin time methods for oral anticoagulant therapy do not agree well using the International Normalized Ratio (INR) units.
    Horsti J
    Scand J Clin Lab Invest; 2003; 63(6):455-6. PubMed ID: 14594327
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of quick and owren prothrombin time with regard to the harmonisation of the International Normalised Ratio (INR) system.
    Horsti J
    Clin Chem Lab Med; 2002 Apr; 40(4):399-403. PubMed ID: 12059082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has the Quick or the Owren prothrombin time method the advantage in harmonization for the International Normalized Ratio system?
    Horsti J
    Blood Coagul Fibrinolysis; 2002 Oct; 13(7):641-6. PubMed ID: 12439151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring oral anticoagulant therapy--INR values for the Owren prothrombin time.
    Jackson CM
    Thromb Haemost; 2004 Feb; 91(2):210-2. PubMed ID: 14961145
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
    Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapy.
    Jackson CM; Esnouf MP; Lindahl TL
    Pathophysiol Haemost Thromb; 2003; 33(1):43-51. PubMed ID: 12853712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False incoagulable PT-INR results in oral anticoagulant therapy.
    Redaelli R; Corno AR; Somaini MG; Gechtman C; Caimi TM; Baudo F; Morra E
    Thromb Res; 2008; 122(1):137-9. PubMed ID: 17996923
    [No Abstract]   [Full Text] [Related]  

  • 8. Sample carryover in PT-INR determination is it an issue in Oral Anticoagulant Therapy control?
    Corno AR; Redaelli R; Caimi TM; Mostarda G; Caruso R; Morra E
    Thromb Res; 2011 Mar; 127(3):279-81. PubMed ID: 21129767
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
    Jonsson M; Hillarp A; Svensson P
    Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Has the time arrived to replace the quick prothrombin time test for monitoring oral anticoagulant therapy?
    Jackson CM; Esnouf MP
    Clin Chem; 2005 Mar; 51(3):483-5. PubMed ID: 15738512
    [No Abstract]   [Full Text] [Related]  

  • 11. International normalized ratio (INR) testing in Europe: between-laboratory comparability of test results obtained by Quick and Owren reagents.
    Meijer P; Kynde K; van den Besselaar AMHP; Van Blerk M; Woods TAL
    Clin Chem Lab Med; 2018 Sep; 56(10):1698-1703. PubMed ID: 29648992
    [No Abstract]   [Full Text] [Related]  

  • 12. A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy.
    Berkovsky A; Sergeeva EV; Suvorov AV; Uljavova IS; Kachalova ND; Klimovich LG; Samsonova NN; Kozlov AA
    Clin Chem Lab Med; 2006; 44(10):1214-7. PubMed ID: 17032133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The international normalized ratio according to Owren in liver disease: interlaboratory assessment and determination of international sensitivity index.
    Magnusson M; Sten-Linder M; Bergquist A; Rajani R; Kechagias S; Fischler B; Németh A; Lindahl TL
    Thromb Res; 2013 Sep; 132(3):346-51. PubMed ID: 23993902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
    Bailleul E; Van Vaerenbergh K; Lust A
    Thromb Haemost; 2005 Sep; 94(3):687; author reply 688. PubMed ID: 16268495
    [No Abstract]   [Full Text] [Related]  

  • 15. The significance of the International Normalized Ratio (INR) for oral anticoagulant therapy.
    van den Besselaar AM
    J Int Fed Clin Chem; 1991 Sep; 3(4):146-53. PubMed ID: 20821873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
    Gouin I; Horellou MH; Conard J; Samama M
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy.
    Pfäfflin A
    Clin Chem Lab Med; 2009; 47(2):242-3. PubMed ID: 19191733
    [No Abstract]   [Full Text] [Related]  

  • 18. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
    Nilsson CU; Strandberg K; Reinstrup P
    Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples.
    Lindahl TL; Egberg N; Hillarp A; Ødegaard OR; Edlund B; Svensson J; Sandset PM; Rånby M
    Thromb Haemost; 2004 Jun; 91(6):1223-31. PubMed ID: 15175811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue.
    Adcock DM; Gosselin RC
    Int J Lab Hematol; 2017 May; 39 Suppl 1():37-40. PubMed ID: 28447415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.